1. Home
  2. ADTN vs PCRX Comparison

ADTN vs PCRX Comparison

Compare ADTN & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$8.92

Market Cap

962.3M

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.84

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTN
PCRX
Founded
1985
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
962.3M
999.0M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
ADTN
PCRX
Price
$8.92
$26.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$15.50
$30.25
AVG Volume (30 Days)
2.1M
506.2K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
90.83
107.44
EPS
N/A
0.07
Revenue
$1,083,807,000.00
$541,533,000.00
Revenue This Year
$11.09
$6.78
Revenue Next Year
$8.47
$8.54
P/E Ratio
N/A
$384.57
Revenue Growth
17.46
26.04
52 Week Low
$7.11
$18.80
52 Week High
$19.98
$27.64

Technical Indicators

Market Signals
Indicator
ADTN
PCRX
Relative Strength Index (RSI) 28.26 N/A
Support Level $8.36 N/A
Resistance Level $9.14 N/A
Average True Range (ATR) 0.59 0.00
MACD -0.12 0.00
Stochastic Oscillator 14.79 0.00

Price Performance

Historical Comparison
ADTN
PCRX

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: